# Zool719-covid19

See [Schedule here](https://docs.google.com/spreadsheets/d/1NJWmhJHhY_MuPiSu9Oii1-UA2HYzqlfMRqr88NlKtHs/edit#gid=0)

1. January 12 Organizational meeting

2. January 19 Literature sharing  
    2.1. (Ethan) Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events
https://science.sciencemag.org/content/early/2020/12/09/science.abe3261  
    2.2 (Claire) Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
https://science.sciencemag.org/content/early/2021/01/06/science.abf4063  
    2.3 (Marguerite) [Update on the new variants of SARS-CoV-2](./2.3.SARS-CoV-2 UK SA Variants HiPAM 1_7_21.pdf)   
    [Viral mutations for sustained human-human and human-animal transmission](https://virological.org/t/mutations-arising-in-sars-cov-2-spike-on- sustained-human-to-human-transmission-and-human-to-animal- passage/578)
    [Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation](https://doi.org/10.1101/2020.12.05.20241927) The first evidence of in vivo SARS-CoV-2 escape from passive antibodies and a cautionary tale for convalescent plasma use on late-stage infection. Typically convalescent plasma is used only in the earliest stages, and repeated use is not recommended. 
    
